M 15 Pill - yellow oval, 11mm
Generic Name: meloxicam
Pill with imprint M 15 is Yellow, Oval and has been identified as Mobic 15 mg. It is supplied by Boehringer Ingelheim Pharmaceuticals, Inc.
Mobic is used in the treatment of Osteoarthritis; Juvenile Rheumatoid Arthritis; Rheumatoid Arthritis and belongs to the drug class Nonsteroidal anti-inflammatory drugs. prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Mobic 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 15




Mobic
- Generic Name
- meloxicam
- Imprint
- M 15
- Strength
- 15 mg
- Color
- Yellow
- Size
- 11.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Nonsteroidal anti-inflammatory drugs
- Pregnancy Category
- C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Boehringer Ingelheim Pharmaceuticals, Inc.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00597-0030 (Discontinued) | Boehringer Ingelheim Pharmaceuticals, Inc. |
54569-5179 (Discontinued) | A-S Medication Solutions, LLC (repackager) |
52959-0663 | H.J. Harkins Company, Inc. (repackager) |
55289-0739 | PDRX Pharmaceuticals Inc. (repackager) |
54868-5158 (Discontinued) | Physicians Total Care Inc. (repackager) |
63874-1110 (Discontinued) | Altura Pharmaceuticals Inc. (repackager) |
68071-0261 (Discontinued) | Nucare Pharmaceuticals Inc. (repackager) |
Related images for "M 15"
More about Mobic (meloxicam)
- Check interactions
- Compare alternatives
- Reviews (131)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: Nonsteroidal anti-inflammatory drugs
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.